MedTrace Logo

Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma

NCT01931696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of this study is to assess whether acupuncture is effective in the treatment of chronic asthma.

Conditions

Interventions

DEVICE

Verum acupuncture

100 patients receive verum acupuncture treatment once every other day,choosing Dazhui(GV14), Fengmen(BL12), Feishu(BL13), needles retention for 30 minutes and no moxibustion or electrical stimulation. Patients receive verum acupuncture once every other day with a total of 20 sessions in 6 weeks. The needle brand is Hwato®™ Sterile Acupuncture Needles for Single Use.

DEVICE

Sham acupuncture

100 patients receive sham acupuncture treatment once every other day, choosing Jinsuo(DU08), Ganshu(BL18), Danshu(BL19), needles retention for 30 minutes and no moxibustion or electrical stimulation. Patients receive sham acupuncture once every other day with a total of 20 sessions in 6 weeks. The needle brand is Hwato®™ Sterile Acupuncture Needles for Single Use.

Sponsors & Collaborators

  • Shanghai Municipal Health Bureau

    collaborator OTHER_GOV

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Yong-Qing Yang, Ph.D · Shanghai University of TCM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-02-28
Completion
2015-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01931696 on ClinicalTrials.gov